Clinical trials
Non-Muscle Invasive Bladder Neoplasms trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 9 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 4 |
| Eli Lilly and Company | 2 |
| University of Rome Tor Vergata | 2 |
| UroGen Pharma Ltd. | 2 |
| A.O.U. Città della Salute e della Scienza | 1 |
| AC.TA. S.r.l. | 1 |
| Bristol-Myers Squibb | 1 |
| Cepheid | 1 |
| Fidia Farmaceutici s.p.a. | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 28 |
| Urinary Bladder Neoplasms | 15 |
| Urinary Bladder Diseases | 3 |
| Urologic Neoplasms | 3 |
| Carcinoma in Situ | 2 |
| Recurrence | 2 |
| Urologic Diseases | 2 |
| Carcinoma | 1 |
| Hyperthermia | 1 |
| Lower Urinary Tract Symptoms | 1 |
Trials
Showing 51 to 28 of 28. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.